![Philips completes installation of its innovative Vereos digital PET/CT system in the Clinique de Genolier - News | Philips Philips completes installation of its innovative Vereos digital PET/CT system in the Clinique de Genolier - News | Philips](https://www.philips.com/c-dam/corporate/newscenter/global/standard/resources/healthcare/2017/vereos-installation/Vereos_Genolier-25-von-25.download.jpg)
Philips completes installation of its innovative Vereos digital PET/CT system in the Clinique de Genolier - News | Philips
![Frontiers | Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era | Oncology Frontiers | Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era | Oncology](https://www.frontiersin.org/files/Articles/697908/fonc-11-697908-HTML/image_m/fonc-11-697908-t001.jpg)
Frontiers | Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era | Oncology
![PDF) Cetuximab Plus Irinotecan in Heavily Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: MABEL Study PDF) Cetuximab Plus Irinotecan in Heavily Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: MABEL Study](https://i1.rgstatic.net/publication/23318936_Cetuximab_Plus_Irinotecan_in_Heavily_Pretreated_Metastatic_Colorectal_Cancer_Progressing_on_Irinotecan_MABEL_Study/links/02e7e515ef6bf5bffe000000/largepreview.png)
PDF) Cetuximab Plus Irinotecan in Heavily Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: MABEL Study
![Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group - Radiotherapy and Oncology Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/03010b11-cdd3-4003-8c17-d480a2c71c5d/gr1_lrg.jpg)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group - Radiotherapy and Oncology
![Philips introduces first commercial MR-only solution for prostate cancer treatment planning in the U.S. - News center | Philips Philips introduces first commercial MR-only solution for prostate cancer treatment planning in the U.S. - News center | Philips](https://www.philips.com/c-dam/corporate/newscenter/global/standard/resources/healthcare/2020/ambient-experience/vereos-genolier-thumb.jpg)